FDA label
What is sulfacetamide used for?
The FDA-approved uses of sulfacetamide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Sulfacetamide sodium ophthalmic solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobact...”
Run it in Rivvi
Which 2027 plans near you dropped or restricted sulfacetamide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Sulfacetamide Sodium, solution/ drops
Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (ANDA040066). Cross-references to other label sections are left out.
Sulfacetamide sodium ophthalmic solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species.
Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa. A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.
Source: DailyMed label, set id 6c1b2658-e756-4f31-9bc8-f99a0baa4637, version 10, effective August 31, 2023. NDC 24208-670, one of 6 listings for this product.
Sulfacetamide Sodium, lotion
Indications and Usage, quoted from the label by Padagis Israel Pharmaceuticals Ltd (ANDA078649). Cross-references to other label sections are left out.
Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) is indicated in the topical treatment of acne vulgaris.
Source: DailyMed label, set id 4fb4d39a-330e-4c84-abbc-3b33b36b206f, version 12, effective April 1, 2023. NDC 45802-896, one of 1 listing for this product.
Sulfacetamide Sodium, solution
Indications and Usage, quoted from the label by Asclemed USA, Inc. (ANDA089560). Cross-references to other label sections are left out.
INDICATIONS AND USAGE: Sulfacetamide Sodium Ophthalmic Solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma:
Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species.
Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa. A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.
Source: DailyMed label, set id c4c29e13-8303-4a9a-bb47-d7413eaf2f26, version 2, effective October 12, 2022. NDC 76420-076, one of 1 listing for this product.
Questions
What is sulfacetamide used for?
The FDA label says: “Sulfacetamide sodium ophthalmic solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobact...”
What drug class is sulfacetamide?
FDA lists sulfacetamide in the Sulfonamide Antibacterial established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.